{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:51:28Z","timestamp":1791388288277,"version":"4.3.3"},"reference-count":12,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,1]],"date-time":"2027-06-01T00:00:00Z","timestamp":1811808000000},"content-version":"am","delay-in-days":243,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jbspin.2026.106077","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:16:13Z","timestamp":1778602573000},"page":"106077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Life-threatening hemorrhage from acquired factor V deficiency with non-inhibitory, hyperclearance-type antibodies successfully treated with rituximab then belimumab"],"prefix":"10.1016","volume":"93","author":[{"given":"Nakako","family":"Tanaka-Mabuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichiro","family":"Hanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojiro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Yazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Takamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ieko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruto","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Nakagomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2026.106077_bib0065","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1055\/s-0044-1787188","article-title":"Diagnosis and treatment of autoimmune acquired coagulation factor deficiencies: an evidence-based review of Japanese practice","volume":"51","author":"Ichinose","year":"2025","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jbspin.2026.106077_bib0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.autrev.2013.08.001","article-title":"Autoantibodies to coagulation factors: from pathophysiology to diagnosis and therapy","volume":"13","author":"Cugno","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2026.106077_bib0075","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11239-010-0529-6","article-title":"Acquired factor V inhibitors: a systematic review","volume":"31","author":"Franchini","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jbspin.2026.106077_bib0080","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/bjh.17308","article-title":"Acquired factor V inhibitor: a nation-wide study of 38 patients","volume":"192","author":"Goulenok","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jbspin.2026.106077_bib0085","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ajh.23241","article-title":"The use of rituximab therapy in patients with acquired factor V inhibitors","volume":"87","author":"Navarrete","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jbspin.2026.106077_bib0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12185-021-03212-9","article-title":"Measurement of coagulation factor antibody levels is useful for diagnosis and determining therapeutic efficacy in hemorrhagic patients with autoantibodies to coagulation factor VIII and factor V: results from a single center in Japan","volume":"115","author":"Ieko","year":"2022","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jbspin.2026.106077_bib0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ajh.20181","article-title":"Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis","volume":"77","author":"Lian","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jbspin.2026.106077_bib0100","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2169\/internalmedicine.53.1552","article-title":"Successful treatment of severe lung hemorrhage caused by acquired factor V inhibitor with rituximab","volume":"53","author":"Yamada","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.jbspin.2026.106077_bib0105","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.3324\/haematol.2020.259481","article-title":"Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase 2b trial","volume":"106","author":"Mah\u00e9vas","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jbspin.2026.106077_bib0110","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.7326\/M21-2078","article-title":"Effectiveness of belimumab after rituximab in systemic lupus erythematosus: a randomized controlled trial","volume":"174","author":"Shipa","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jbspin.2026.106077_bib0115","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1093\/rheumatology\/kead171","article-title":"Early glucocorticoid withdrawal by combining rituximab with belimumab in two patients with lupus-associated thrombocytopenia","volume":"62","author":"Hanai","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2026.106077_bib0120","doi-asserted-by":"crossref","first-page":"102887","DOI":"10.1016\/j.jaut.2022.102887","article-title":"Systemic lupus erythematosus-complicating immune thrombocytopenia: from pathogenesis to treatment","volume":"132","author":"Jiang","year":"2022","journal-title":"J Autoimmun"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X26000461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X26000461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:56:05Z","timestamp":1791384965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X26000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1297319X26000461"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2026.106077","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Life-threatening hemorrhage from acquired factor V deficiency with non-inhibitory, hyperclearance-type antibodies successfully treated with rituximab then belimumab","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2026.106077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise de Rhumatologie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106077"}}